JP2005519617A5 - - Google Patents

Download PDF

Info

Publication number
JP2005519617A5
JP2005519617A5 JP2003575917A JP2003575917A JP2005519617A5 JP 2005519617 A5 JP2005519617 A5 JP 2005519617A5 JP 2003575917 A JP2003575917 A JP 2003575917A JP 2003575917 A JP2003575917 A JP 2003575917A JP 2005519617 A5 JP2005519617 A5 JP 2005519617A5
Authority
JP
Japan
Prior art keywords
polypeptide
seq
amino acid
set forth
nucleotide sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003575917A
Other languages
English (en)
Japanese (ja)
Other versions
JP4733349B2 (ja
JP2005519617A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/007775 external-priority patent/WO2003077863A2/en
Publication of JP2005519617A publication Critical patent/JP2005519617A/ja
Publication of JP2005519617A5 publication Critical patent/JP2005519617A5/ja
Application granted granted Critical
Publication of JP4733349B2 publication Critical patent/JP4733349B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003575917A 2002-03-13 2003-03-13 両性イオン多糖の過剰発現の方法 Expired - Fee Related JP4733349B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36416802P 2002-03-13 2002-03-13
US60/364,168 2002-03-13
PCT/US2003/007775 WO2003077863A2 (en) 2002-03-13 2003-03-13 Method for overexpression of zwitterionic polysaccharides

Publications (3)

Publication Number Publication Date
JP2005519617A JP2005519617A (ja) 2005-07-07
JP2005519617A5 true JP2005519617A5 (enExample) 2006-04-20
JP4733349B2 JP4733349B2 (ja) 2011-07-27

Family

ID=28041884

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003575917A Expired - Fee Related JP4733349B2 (ja) 2002-03-13 2003-03-13 両性イオン多糖の過剰発現の方法

Country Status (7)

Country Link
US (4) US7166455B2 (enExample)
EP (1) EP1483384B1 (enExample)
JP (1) JP4733349B2 (enExample)
AT (1) ATE541036T1 (enExample)
AU (2) AU2003218144B2 (enExample)
CA (1) CA2479246C (enExample)
WO (1) WO2003077863A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7083777B1 (en) * 1999-04-02 2006-08-01 The Brigham And Women's Hospital, Inc. Immunomodulating polymers
SV2003000753A (es) 2000-12-05 2003-06-16 Brigham & Womens Hospital Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico
CA2479246C (en) * 2002-03-13 2017-05-09 Laurie E. Comstock Method for overexpression of zwitterionic polysaccharides
CA2520865A1 (en) * 2003-03-31 2004-10-21 The Brigham And Women's Hospital, Inc. Zwitterionic immunomodulators for the treatment of asthma and allergy
BRPI0415764A (pt) 2003-11-28 2006-12-26 Eastman Chem Co interpolìmero, produto de reação, métodos para converter uma hidroxila, para preparar uma forma estável de um interpolìmero, para converter um álcool primário, e para tratar um mamìfero necessitado do mesmo, composições para revestimento e farmacêutica oral, dispersão de pigmento, e, artigo
WO2007092451A2 (en) * 2006-02-06 2007-08-16 The Brigham And Women's Hospital, Inc. Zwitterionic polysaccharides for promotion of immune system maturation and health
US20110002965A1 (en) * 2007-11-09 2011-01-06 Round June L Immunomodulating compounds and related compositions and methods
US20090124573A1 (en) * 2007-11-09 2009-05-14 Sarkis Mazmanian Immunomodulating compounds and related compositions and methods
US8580278B2 (en) 2009-06-03 2013-11-12 Trustees Of Dartmouth College Nutraceutical composition and methods for preventing or treating multiple sclerosis
US20100311686A1 (en) * 2009-06-03 2010-12-09 Kasper Lloyd H Nutraceutical composition and methods for preventing or treating multiple sclerosis
EP2555753B1 (en) 2010-04-07 2018-08-01 California Institute of Technology Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
WO2011146910A1 (en) 2010-05-20 2011-11-24 Round June L Antigen specific tregs and related compositions, methods and systems
JP6273200B2 (ja) 2011-07-12 2018-01-31 ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド 脂質含有psa組成物、その単離の方法および使用の方法
EP2764090B1 (en) * 2011-10-03 2017-12-13 California Institute of Technology Generation of psa-only producing mutant strain
CA2911826C (en) 2013-05-10 2022-08-23 California Institute Of Technology Probiotic prevention and treatment of colon cancer
US11331335B2 (en) 2015-06-10 2022-05-17 California Institute Of Technology Sepsis treatment and related compositions methods and systems
CN113637040A (zh) * 2015-08-19 2021-11-12 哈佛学院院长及董事 脂化psa组合物和方法
US11491181B2 (en) 2016-07-15 2022-11-08 President And Fellows Of Harvard College Glycolipid compositions and methods of use

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS618945A (ja) 1984-06-25 1986-01-16 Nec Corp 半導体集積回路装置
EP0273040B1 (en) 1986-03-26 1994-06-22 GX BioSystems A/S Biological containment
US4952524A (en) 1989-05-05 1990-08-28 At&T Bell Laboratories Semiconductor device manufacture including trench formation
KR940006696B1 (ko) 1991-01-16 1994-07-25 금성일렉트론 주식회사 반도체 소자의 격리막 형성방법
US5350941A (en) 1992-09-23 1994-09-27 Texas Instruments Incorporated Trench isolation structure having a trench formed in a LOCOS structure and a channel stop region on the sidewalls of the trench
US5433794A (en) 1992-12-10 1995-07-18 Micron Technology, Inc. Spacers used to form isolation trenches with improved corners
JPH07326664A (ja) 1994-05-31 1995-12-12 Fuji Electric Co Ltd ウエハの誘電体分離溝の充填方法
US5700787A (en) * 1994-09-02 1997-12-23 Brigham & Women's Hospital, Inc. Capsular polysaccharide immunomodulator
US5679654A (en) 1994-09-02 1997-10-21 Brigham & Women's Hospital, Inc. Capsular polysaccharide immunomodulator
US5851808A (en) 1997-02-28 1998-12-22 Baylor College Of Medicine Rapid subcloning using site-specific recombination
US7083777B1 (en) * 1999-04-02 2006-08-01 The Brigham And Women's Hospital, Inc. Immunomodulating polymers
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
SV2003000753A (es) 2000-12-05 2003-06-16 Brigham & Womens Hospital Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico
CA2479246C (en) * 2002-03-13 2017-05-09 Laurie E. Comstock Method for overexpression of zwitterionic polysaccharides
CA2520865A1 (en) 2003-03-31 2004-10-21 The Brigham And Women's Hospital, Inc. Zwitterionic immunomodulators for the treatment of asthma and allergy

Similar Documents

Publication Publication Date Title
JP2005519617A5 (enExample)
TW494138B (en) Methods of producing hydrophobic polypeptides in E coli
JP2003532365A5 (enExample)
KR20160067219A (ko) 저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
JP2018537087A5 (enExample)
JP2003516731A5 (enExample)
WO1999043819B1 (en) Family of maize pr-1 genes and promoters
JP2005514901A5 (enExample)
JP2024028452A5 (enExample)
JP2004506432A5 (enExample)
CA2337100A1 (en) Polypeptides of lymphodendritic cell adhesion molecules (ldcams) and polynucleotides encoding the same
KR101700974B1 (ko) 친화성 태그가 결합된 융합 콜라게나제 및 그의 제조방법
JP2003530817A5 (enExample)
CN106243229B (zh) 具有三螺旋结构的蛋白质物质及其制造方法
JP2003527078A5 (enExample)
CA2461443A1 (en) Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
JP2018537089A5 (enExample)
JP2008545436A5 (enExample)
JP2002517193A5 (enExample)
JP2005528124A5 (enExample)
EP3088520B1 (en) Improved beta-fructofuranosidase
JP2002501077A5 (enExample)
JP2020127419A5 (enExample)
JP2019520083A5 (enExample)
JP2003512841A5 (enExample)